No changes in efavirenz plasma concentrations in HIV-infected patients who switch from Stocrin to Atripla

J Acquir Immune Defic Syndr. 2010 Aug;54(5):e12-3. doi: 10.1097/QAI.0b013e3181ed1896.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / analogs & derivatives*
  • Adenine / pharmacokinetics
  • Alkynes
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / pharmacokinetics*
  • Benzoxazines / administration & dosage*
  • Benzoxazines / pharmacokinetics*
  • Cyclopropanes
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / pharmacokinetics
  • Drug Combinations
  • Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • HIV Infections / drug therapy
  • Humans
  • Organophosphonates / administration & dosage*
  • Organophosphonates / pharmacokinetics*
  • Oxazines / administration & dosage*
  • Oxazines / pharmacokinetics*
  • Plasma / chemistry*

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Drug Combinations
  • Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Organophosphonates
  • Oxazines
  • Deoxycytidine
  • Adenine
  • efavirenz